Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combined Inhibition of Akt and mTOR Is Effective Against Non-Hodgkin Lymphomas. | Front Oncol | 2021 | 34221985 | PubTator, text mining | PubMed |
| The Novel Oral mTORC1/2 Inhibitor TAK-228 Reverses Trastuzumab Resistance in HER2-Positive Breast Cancer Models. | Cancers (Basel) | 2021 | 34204960 | PubTator, text mining | PubMed |
| Responsiveness to Hedgehog Pathway Inhibitors in T-Cell Acute Lymphoblastic Leukemia Cells Is Highly Dependent on 5'AMP-Activated Kinase Inactivation. | Int J Mol Sci | 2021 | 34203724 | PubTator, text mining | PubMed |
| The genetic association of the transcription factor NPAT with glycemic response to metformin involves regulation of fuel selection. | PLoS One | 2021 | 34197485 | PubTator, text mining | PubMed |
| SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome. | Nat Commun | 2021 | 34193871 | PubTator, text mining | PubMed |
| Inhibition of RPS6K reveals context-dependent Akt activity in luminal breast cancer cells. | PLoS Comput Biol | 2021 | 34191793 | PubTator, text mining | PubMed |
| Inhibitors of PD-1/PD-L1 and ERK1/2 impede the proliferation of receptor positive and triple-negative breast cancer cell lines. | J Cancer Res Clin Oncol | 2021 | 34185141 | PubTator, text mining | PubMed |
Normalization of Enzyme Expression and Activity Regulating Vitamin A Metabolism Increases RAR-Beta Expression and Reduces Cellular Migration and Proliferation in Diseases Caused by Tuberous Sclerosis Gene Mutations. | Front Oncol | 2021 | 34178631 | PubTator, text mining | PubMed |
| Impaired myelin production due to an intrinsic failure of oligodendrocytes in mTORpathies. | Neuropathol Appl Neurobiol | 2021 | 34173252 | PubTator, text mining | PubMed |
| Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth. | Nat Chem Biol | 2021 | 34168367 | PubTator, text mining | PubMed |
| The costimulatory activity of Tim-3 requires Akt and MAPK signaling and its recruitment to the immune synapse. | Sci Signal | 2021 | 34131021 | PubTator, text mining | PubMed |
| A novel somatic mutation in GNB2 provides new insights to the pathogenesis of Sturge-Weber syndrome. | Hum Mol Genet | 2021 | 34124757 | PubTator, text mining | PubMed |
| Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer. | Front Oncol | 2021 | 34123846 | PubTator, text mining | PubMed |
| Rapid and Durable Response With Nab-Sirolimus After Everolimus Failure in a Patient With Perivascular Epithelioid Cell Tumors (PEComas) of the Uterus. | Cureus | 2021 | 34123648 | PubTator, text mining | PubMed |
| Early Changes in [18F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts. | Mol Imaging | 2021 | 34113218 | PubTator, text mining | PubMed |
| Overcoming resistance to BRAFV600E inhibition in melanoma by deciphering and targeting personalized protein network alterations. | NPJ Precis Oncol | 2021 | 34112933 | PubTator, text mining | PubMed |
| Immune Activation Induces Telomeric DNA Damage and Promotes Short-Lived Effector T Cell Differentiation in Chronic HCV Infection. | Hepatology | 2021 | 34110660 | PubTator, text mining | PubMed |
| Exploring the Challenges of Social-Emotional Learning Integration in Secondary Schools: A Phenomenological Research in Vietnam. | Psychol Res Behav Manag | 2021 | 34093045 | PubTator, text mining | PubMed |
| Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma. | Clin Cancer Res | 2021 | 34083237 | PubTator, text mining | PubMed |
| Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile Cancer. | Cancers (Basel) | 2021 | 34066040 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=33